Cleared Traditional

K241179 - Rhythm Express Remote Cardiac Monitoring System (RX-1 mini) (FDA 510(k) Clearance)

Jul 2025
Decision
438d
Days
Class 2
Risk

K241179 is an FDA 510(k) clearance for the Rhythm Express Remote Cardiac Monitoring System (RX-1 mini). This device is classified as a Outpatient Cardiac Telemetry (Class II - Special Controls, product code QYX).

Submitted by Vivaquant, Inc. (Arden Hills, US). The FDA issued a Cleared decision on July 11, 2025, 438 days after receiving the submission on April 29, 2024.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1025. Devices Are Intended To Continuously Record And Analyze Electrocardiograms For Automatic Detection And Recording Of Cardiac Electrical Activity In An Outpatient Setting. Detected, Notifiable Events Are Transmitted To The Prescribing Clinician During The Monitoring Period By A 24/7 Attended Analysis Center After Review By A Qualified Individual. Devices May Allow Remote Access And Display Of Electrocardiograms Acquired. Not For Use For Detection Or Notification Of Hemodynamically Unstable Or Life-threatening Arrhythmias Or Cardiac Events Requiring Urgent Medical Response. Not Intended For Patients At Elevated Risk Of Serious Cardiovascular Events That Would Require Prompt Intervention. It Is Not Intended For Monitoring Patients During Cardiac Rehabilitation Outside Of Healthcare Facilities. Devices Are Intended For Prescription Use Only..

Submission Details

510(k) Number K241179 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 29, 2024
Decision Date July 11, 2025
Days to Decision 438 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code QYX - Outpatient Cardiac Telemetry
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1025
Definition Devices Are Intended To Continuously Record And Analyze Electrocardiograms For Automatic Detection And Recording Of Cardiac Electrical Activity In An Outpatient Setting. Detected, Notifiable Events Are Transmitted To The Prescribing Clinician During The Monitoring Period By A 24/7 Attended Analysis Center After Review By A Qualified Individual. Devices May Allow Remote Access And Display Of Electrocardiograms Acquired. Not For Use For Detection Or Notification Of Hemodynamically Unstable Or Life-threatening Arrhythmias Or Cardiac Events Requiring Urgent Medical Response. Not Intended For Patients At Elevated Risk Of Serious Cardiovascular Events That Would Require Prompt Intervention. It Is Not Intended For Monitoring Patients During Cardiac Rehabilitation Outside Of Healthcare Facilities. Devices Are Intended For Prescription Use Only.